National Academies Press: OpenBook

Contraceptive Research and Development: Looking to the Future (1996)

Chapter: Appendix E: Agendas and Participants in Committee Workshops

« Previous: Appendix D: Barrier Methods and Mucosal Immunologic Approaches
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

E: Agendas and Participants in Committee Workshops

Workshop on Contraceptive Research and Development and the Frontiers of Contemporary Science

December 8-9, 1994

Room 130, Cecil and Ida Green Building

2001 Wisconsin Avenue, NW

Washington, DC 20015

Thursday , December 8 , 1994

8:45 a.m

WELCOME

Allan Rosenfield, chair

Polly Harrison

9:00 a.m.

OPENING REMARKS

Kenneth Shine

Mahmoud Fathalla

9:30 a.m.

MALE CONTRACEPTION

William Bremner, overview

Frank French

David Hamilton

Geoffrey Waites

10:15 a.m.

MENSES INDUCERS

Paul Van Look, overview

Horacio Croxatto

11:00 a.m.

BARRIERS AGAINST STD/HIV AND HIV ATTACHMENT-PREVENTION

Nancy Alexander, overview

Lourens Zaneveld

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

11:45 a.m.

VACCINES

Paul Primakoff, overview

John Herr

12:30 p.m.

LUNCH

1:30 p.m.

New Thoughts About Old Ideas

Henry Gabelnick

2:00 p.m.

AREA 1—BASIC GENETICS

Genetic screening and mapping, gene expression, and transcription factors

Moderator:

Bert O'Malley

Principals:

Walter Gilbert

Donald McDonnell

David Page

Allen Spradling

3:30 p.m.

AREA 2—CONTROL/ACTION

Signal transduction, releasing factors, RAFT proteins, ion channels,

peptide receptors, and steroid hormone synthesis

Moderator:

Jerome Strauss

Principals:

Bertil Hille

Andrés Negro-Vilar

Neena Schwartz

Roy Smith

Robert Stein

5:00 p.m.

ADJOURN

6:00 p.m.

Reception/Buffet

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Friday , December 9 , 1994

9:00 a.m.

AREA 3-PRE-FERTILIZATION TO FERTILIZATION

Apoptosis, ovulation and the ovaries, meiotic and mitotic cell cycles,

mammalian fertilization, molecular basis of gamete interaction, and signalling pathways

Moderator:

David Garbers

Principals:

Aaron Hsueh

William Lennarz

JoAnne Richards

Patricia Saling

Debra Wolgemuth

10:30 a.m.

AREA 4-POST-FERTILIZATION TO IMPLANTATION

Angiogenesis, apoptosis, and implantation (cytokine function, integrin biology, and trophoblast invasion)

Moderator:

Susan Fisher

Principals:

Mina Bissell

Michael Harper

Judah Folkman

Bruce Lessey

12:00 p.m.

LUNCH

1:00 p.m.

AREA 5-METHODOLOGIES

Combinatorial chemistry, appropriate modelling

Walter Moos

Jeffrey Harris

1:30 p.m.

AREA 6-INFECTIOUS DISEASES AND IMMUNOLOGY

Deborah Anderson

Jiri Mestecky

3:00 p.m.

REVIEW PANEL

Horacio Croxatto

Egon Diczfalusy

Bert O'Malley

4:00 p.m.

ADJOURN

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Saturday , December 9 , 1994

8:30 a.m.

Executive Session of the Committee

12:00 p.m.

ADJOURN

Workshop Participants

Nancy J. Alexander

Chief, Contraceptive Development Branch

Center for Population Research

National Institute for Child Health and Human Development

National Institutes of Health

Deborah J. Anderson

Associate Professor

Harvard Medical School

Fearing Research Laboratory

Felice M. Apter

Center for Population, Health, and Nutrition

Bureau for Global Programs

U.S. Agency for International Development

Hedia Belhadj El Ghouayel

Technical and Evaluation Division

United Nations Population Fund

Balbir Bhogal

Director of Immunology

Zonagen, Inc.

Gabriel Bialy

Acting Deputy Director

Center for Population Research

National Institute for Child Health and Human Development

National Institutes of Health

Mina J. Bissell

Director

Life Sciences Division

Lawrence Berkeley Laboratory

William J. Bremner

Professor and Vice Chairman

Department of Medicine

University of Washington

Donald D. Brown

Director

Department of Embryology

Carnegie Institute of Washington

Nancy L. Buc

Partner

Buc and Beardsley

Washington, DC

Peter F. Carpenter

Founder/Director

Mission and Values Institute

Stanford University

Willard Cates, Jr.

Director, Division of Training

Centers for Disease Control and Prevention

Rebecca J. Cook

Associate Professor

Faculty of Law

University of Toronto

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Horacio B. Croxatto

Professor

Instituto Chileno de Medicina

Egon Diczfalusy

Professor Emeritus

Karolinska Hospital

Laneta Dorflinger

Director

Clinical Trials Division

Family Health International

Richard H. Douglas

Vice President for Corporate Development

Genzyme Corporation

Mahmoud F. Fathalla

Senior Advisor for Biomedical and Reproductive Health Research

The Rockefeller Foundation, and Professor of Obstetrics and Gynaecology

Assiut University

Susan J. Fisher

Professor and Chair

Division of Oral Biology

University of California at San Francisco

Jonathan J. Fleming

General Partner

Matrushka Venture Capital (MVC)

Judah M. Folkman

Professor of Pediatrics

Harvard Medical School

Frank S. French

Director

Laboratories for Reproductive Biology

Department of Pediatrics

School of Medicine

University of North Carolina at Chapel Hill

Henry L. Gabelnick

Director and Principal Investigator

Contraceptive Research and Development (CONRAD) Program

Professor, Department of Obstetrics and Gynecology

Eastern Virginia Medical School

David L. Garbers

Professor of Pharmacology

Howard Hughes Medical Institute

University of Texas Southwestern Medical Center

Walter Gilbert

Professor

Harvard University

The Biological Laboratories

Allan Goldhammer

Director for Research Activities

Biotechnology Industry Organization (BIO)

David W. Hamilton

Professor and Head

Department of Cell Biology and Neuroanatomy

University of Minnesota

Michael J.K. Harper

Professor

Department of Obstetrics and Gynecology

Baylor College of Medicine

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Jeffrey D. Harris

Director of Molecular Biology

Zonagen, Inc.

Polly F. Harrison

Study Director

Division of Health Sciences Policy

Institute of Medicine

John M. Herr, Jr.

Professor of Cell Biology

Director, Center for Recombinant Gamete Vaccinology

University of Virginia Medical School

Bertil Hille

Professor

Department of Physiology

University of Washington

Gregory F. Hollis

Director

Cellular and Molecular Biology

Merck Research Laboratories

Aaron J.W. Hsueh

Professor

Department of Obstetrics and Gynecology

Stanford University Medical Center

Timothy Kanaley

Research Assistant

Division of Health Sciences Policy

Institute of Medicine

William J. Lennarz

Department of Biochemistry and Cell Biology

State University of New York

Bruce A. Lessey

Department of Obstetrics and Gynecology

University of North Carolina

Dennis W. Lincoln

Director

Reproductive Unit, Edinburgh

Medical Research Council

Carolyn Makinson

Program Officer

Population Program

Andrew W. Mellon Foundation

Donald P. McDonnell

Associate Professor of Pharmacology

Duke University Medical Center

Jiri Mestecky

Professor

Department of Microbiology

University of Alabama

Walter H. Moos

Chemical Therapeutics Research

Chiron Corporation

David C. Mowery

Associate Professor of Business and Public Policy

University of California at Berkeley

Andrés F. Negro-Vilar

Director

Women's Health Research Institute, and Vice President

Wyeth-Ayerst Research

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Bert W. O'Malley

Professor and Chair

Department of Cell Biology

Baylor College of Medicine

David Page

Whitehead Institute for Biomedical Research

Massachusetts Institute of Technology

Sandra Panem

President

Vector Fund Management

Gordon W. Perkin

President

Program for Appropriate Technology in Health (PATH)

Joseph S. Podolski

President and Chief Executive Officer

Zonagen, Inc.

Paul Primakoff

Department of Molecular and Cell Biology

University of California at Davis

JoAnne S. Richards

Professor

Department of Cell Biology

Baylor College of Medicine

Allan Rosenfield (Committee Chair)

Dean, and DeLamar Professor of Public Health, and Professor of Obstetrics and Gynecology

Columbia University School of Public Health

Patricia M. Saling

Associate Professor

Department of Obstetrics and Gynecology

Duke University Medical Center

Neena B. Schwartz

Professor

Department of Neurobiology

Northwestern University

Bennett M. Shapiro

Executive Vice President

Worldwide Basic Research

Merck Research Laboratories

Valerie Setlow

Director

Division of Health Sciences Policy

Institute of Medicine

Kenneth I. Shine

President

Institute of Medicine

Steven W. Sinding

Director

Population Sciences

The Rockefeller Foundation

Roy P. Smith

Department of Biochemistry

Merck Research Laboratories

Jeffrey Spieler

Senior Biomedical Research Advisor

Center for Population, Health, and Nutrition

Bureau for Global Programs

United States Agency for International Development

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Allan C. Spradling

Staff Member

Howard Hughes Medical Institute

Carnegie Institute of Washington

Jacqueline Sherris

Editor, Outlook

Program for Appropriate Technology in Health (PATH)

Robert Stein

Senior Vice President, and Chief Scientific Officer

Ligand Pharmaceuticals

Jerome F. Strauss, III

Professor and Director

Center for Research on Women's Health

University of Pennsylvania

Laura Tangley

Science Writer for the Institute of Medicine

Paul Van Look

Associate Director

Special Programme of Research, Development, and Research Training in Human Reproduction

World Health Organization

Geoffrey M.H. Waites

President, International Society for Andrology

Kevin J. Whaley

Research Scientist

Department of Biophysics

Johns Hopkins University

Debra J. Wolgemuth

Professor of Human Genetics and Development

College of Physicians and Surgeons

Columbia University

Lourens J. D. Zaneveld

Research Director

Women's Health Research Center

Professor

Department of Obstetrics and Gynecology, and Department of Biochemistry

Rush University, St. Luke's Medical Center

Bai-ge Zhao

Director

Shanghai Institute of Planned Parenthood Research

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Agenda

Workshop on Private Sector Participation in Contraceptive Research and Development: Opportunities, Challenges, Strategies

May 11-12, 1995

Room 130, Cecil and Ida Green Building

2001 Wisconsin Avenue, NW

Washington, DC 20015

Thursday , May 11 , 1995

8:45 a.m.

Welcome

Introduction of Participants

Adoption of Agenda and Timetable

Allan Rosenfield, Chair

(All presentations on the rest of Day I will be of a length that will permit ample time for discussion.)

Session 1: What We Have Done So Far

9:15 a.m.

Thoughts and Conclusions from Bellagio Conference,

April 10-14, 1995, on Public- and Private Sector Collaboration

in Contraceptive Research and Development

Mahmoud Fathalla

10:00 a.m.

Findings from IOM Workshop on Contraceptive Research and

Development and the Frontiers of Science, December 8-9, 1994

The Farther Frontier

David Garbers

The Middle Ground

Andrés Negro-Vilar

11:00 a.m.

Break

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Session 2: Challenges and Questions

11:15 a.m.

Defining the Market:

What Are the Needs?

Jacqueline Forrest

What Is the Market?—Measures and Calculations

William Sheldon

12:15 p.m.

Lunch

1:30 p.m.

The Legal and Regulatory Scene:

Changes and Perspectives at the FDA

Philip Corfman

Tort Reform Update

Ellen Flannery

2:30 p.m.

Industry Perspectives: A Panel Discussion

Robert Essner

Michael Kafrissen

Hans Vemer

Guenter Stock

3:45 p.m.

Break

4:00 p.m.

Instructions to Working Groups: Objectives and Framework for Discussions

Allan Rosenfield/Polly Harrison

(The composition of each Working Group will be balanced among the expertises and backgrounds of the participant group as a whole. A set of draft questions for the Groups is attached to this agenda.)

4:30 p.m.

What Are the Most Important Political Perspectives in the

United States and How Might These Be Taken into Account?

The Honorable Nita M. Lowey

The Honorable Constance A. Morella

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

5:30 p.m.

Adjourn

Buffet Reception

7:30 p.m.

Brief Meeting of Each Working Group to Organize Itself and Marshal Initial Thoughts

Friday , May 12 , 1995

8:45 a.m.

Reconvene Briefly in Room 130 for trouble-shooting, questions, clarifications, et cetera.

9:00 a.m.

Working Groups (continued) and Preparation of Working Group Reports

12:00 p.m.

Lunch

1:00 p.m.

Working Group Presentations by Rapporteurs

Response Panel and Discussion

Conclusions, Recommendations, Followup

[A panel of individuals with expertise in the areas addressed on Day 1 will react to the conclusions and recommendations reported by each group , and moderate comments from the workshop audience as a whole.]

4:00 p.m.

Adjournment

4:15 p.m.

Meeting of Committee and Sponsors

5:15 p.m.

Full Adjournment

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Workshop Participants

Nancy J. Alexander**

Chief, Contraceptive Development

Center for Population Research

National Institute for Child Health and Human Development

National Institutes of Health

Hedia Belhadj-El Ghouayel*

Technical and Evaluation Division

United Nations Population Fund

Willem Bergink

Program Manager for Reproductive Medicine

Organon International B.V.

Seth Berkley**

Acting Director for Health Sciences

The Rockefeller Foundation

Enriqueta C. Bond

President

The Burroughs Wellcome Fund

Lance Bronnenkant

President and Chief Executive Officer

Finishing Enterprises, USA

Donald D. Brown*

Director

Department of Embryology

Carnegie Institute of Washington

Barbara Brummer

Advanced Care Products

Nancy L. Buc*

Partner

Buc, Levitt, and Beardsley

Stephanie Burns

Manager, FDA and Women's Health

Dow Corning Corporation

Peter F. Carpenter*

Founder/Director, Mission and Values Institute

Visiting Scholar, Center for Biomedical Ethics

Stanford University

Willard Cates, Jr.*

Director

Division of Training

Epidemiology Program Office

Centers for Disease Control and Prevention

James Cavanaugh

President

HealthCare Investment Corporation

Scott Chappel

Senior Scientific Advisor

Ares-Serono

Michael Cohen

Scientific Director

Applied Medical Research, Ltd.

Philip A. Corfman

Supervisory Medical Officer for Fertility and Maternal Health

U.S. Food and Drug Administration

Rebecca J. Cook*

Associate Professor, Faculty of Law

University of Toronto

*  

Committee Member

**  

Sponsor Representative

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Horacio B. Croxatto*

Professor

Instituto Chileno de Medicina Reproductiva

Bernard M. Dickens

Professor, Faculty of Law, Faculty of Medicine

Centre of Criminology and Centre for Bioethics

University of Toronto

Laneta Dorflinger

Family Health International

Richard H. Douglas*

Vice President, Corporate Development

Genzyme Corporation

Robert Essner

President

Wyeth-Ayerst Laboratories

Mahmoud F. Fathalla**

Senior Advisor for Biomedical and Reproductive Health Research

The Rockefeller Foundation, and

Professor of Obstetrics and Gynaecology

Assiut University

Diane Feldman

Vice President for Over-the-Counter Business

Syntex Corporation

Alan Ferguson

Atlas Venture

Mary Flack

Parke-Davis Pharmaceutical Research

Warner-Lambert Co.

Ellen Flannery

Partner

Covington and Burling

Jonathan Fleming

Matrushka Venture Capital (MVC)

Jacqueline D. Forrest

Director of Research

The Alan Guttmacher Institute

Adrian Fugh-Berman**

Contraceptive Development Branch

National Institute for Child Health and Human Development

National Institutes of Health

Henry L. Gabelnick**

Director

Contraceptive Research and Development (CONRAD) Program

Professor, Department of Obstetrics and Gynecology

Eastern Virginia Medical School

David L. Garbers

Patrick E. Haggerty Distinguished Chair in Basic Biomedical Science

Howard Hughes Medical Institute

University of Texas Southwestern Medical Center at Dallas

Philip Gevas

President and Chief Executive Officer

Aphton Pharmaceuticals

Michael J.K. Harper*

Professor, Department of Obstetrics and Gynecology

Baylor College of Medicine

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Polly F. Harrison

Study Director

Division of Health Sciences Policy

Institute of Medicine

Robert Howells

Director, Population Initiative

The Wellcome Trust

Leonard Jacob

Executive Vice President and Chief Operating Officer

Magainin Pharmaceuticals

Michael Kafrissen

Vice President for Clinical Affairs

Ortho-McNeil

Timothy Kanaley

Research Assistant

Division of Health Sciences Policy

Institute of Medicine

David H. Katz

Chief Executive Officer and President

Lidak Pharmaceuticals

Walter Klemann

Head, Strategic Business Unit, Fertility Control and Hormone Therapy

Schering AG

Susan Lambert

Vice-President

J&J Development Corporation

Ortho-McNeil Pharmaceutical

Samuel Lin

Assistant Surgeon General (Ret.), US Public Health Service, and

Executive Director, Federal Medical Affairs

The Upjohn Company

Ernest Loumaye

Corporate Ob/Gyn Director

Medical Affairs Department

Serono Corporation

Carolyn Makinson**

Program Officer

Population Program

Andrew W. Mellon Foundation

Donald Patrick McDonnell*

Associate Professor of Pharmacology

Department of Pharmacology

Duke University Medical Center

Jonathan Miles Brown

Director of Technical Marketing

Martek Biosciences

Jonathan Missner

Vice President, Operations

Applied Medical Research, Ltd.

David C. Mowery*

Professor of Business and Public Policy

Walter A. Haas School of Business

University of California at Berkeley

Andrés Negro-Vilar

Director, Women's Health Research Institute, and

Vice President

Wyeth-Ayerst Research

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Mark J. Newman

Vice President, Research and Development

Vaxcel, Inc.

Judy Norsigian*

Codirector

Boston Women's Health Book Collective

Robert O'Neill

Vice-President

J&J Development Corporation

Ortho-McNeil Pharmaceuticals

Sandra Panem*

President

Vector Fund Management

Audrey Phillips

Research Manager

Department of Reproductive Research

R. W. Johnson Pharmaceutical Research Institute

Jonathan Rosen

Director, Transcription Research

Ligand Pharmaceuticals

Allan Rosenfield (Committee Chair)*

Dean, and DeLamar Professor of Public Health, and

Professor of Obstetrics and Gynecology

Columbia University School of Public Health

Jean Rowan

Director, Clinical Programs

Parke-Davis Pharmaceutical Research

Warner-Lambert Co.

Ekkehard Schillinger

Head of Research

Schering AG

Sheldon Segal

Distinguished Scientist

The Population Council

Valerie Setlow

Director

Division of Health Sciences Policy

Institute of Medicine

Bennett M. Shapiro*

Executive Vice President

Worldwide Basic Research

Merck Research Laboratories

William C. Sheldon

President and Chief Executive Officer

Applied Medical Research, Ltd.

Kenneth I. Shine

President

Institute of Medicine

Steven Sinding**

Director, Population Sciences

The Rockefeller Foundation

Jeffrey Spieler**

Senior Biomedical Research Advisor, Office of Population

Center for Population, Health, and Nutrition

Bureau for Global Programs

United States Agency for International Development

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×

Felicia Stewart

Deputy Assistant Secretary for Population Affairs

Department of Health and Human Services, Public Health Service

Pamela Stratton**

Special Assistant in Gynecology and Clinical Research

Contraceptive Development Branch

National Institute of Child Health and Human Development

National Institutes of Health

Laura Tangley

Science Writer for the Institute of Medicine

Wylie Vale*

Professor

The Clayton Foundation Laboratories for Peptide Biology

The Salk Institute

Hans M. Vemer

Director of Research and Medical Director

Organon International B.V.

David Woo

President and Chief Scientific Officer

Immunotherapy Corporation

Craig Wright

Vice President of Research and Development

Novovax

Lourens J. D. Zaneveld

Research Director

Women's Health Research Center

Professor, Department of Obstetrics and Gynecology, and Department of Biochemistry

Rush University, Rush-St. Luke's Medical Center

Bai-ge Zhao*

Director

Shanghai Institute of Planned Parenthood Research

Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 474
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 475
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 476
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 477
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 478
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 479
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 480
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 481
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 482
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 483
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 484
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 485
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 486
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 487
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 488
Suggested Citation:"Appendix E: Agendas and Participants in Committee Workshops." Institute of Medicine. 1996. Contraceptive Research and Development: Looking to the Future. Washington, DC: The National Academies Press. doi: 10.17226/5156.
×
Page 489
Next: Appendix F: Committee Biographies »
Contraceptive Research and Development: Looking to the Future Get This Book
×
Buy Hardback | $75.00 Buy Ebook | $59.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The "contraceptive revolution" of the 1960s and 1970s introduced totally new contraceptive options and launched an era of research and product development. Yet by the late 1980s, conditions had changed and improvements in contraceptive products, while very important in relation to improved oral contraceptives, IUDs, implants, and injectables, had become primarily incremental. Is it time for a second contraceptive revolution and how might it happen?

Contraceptive Research and Development explores the frontiers of science where the contraceptives of the future are likely to be found and lays out criteria for deciding where to make the next R&D investments.

The book comprehensively examines today's contraceptive needs, identifies "niches" in those needs that seem most readily translatable into market terms, and scrutinizes issues that shape the market: method side effects and contraceptive failure, the challenge of HIV/AIDS and other sexually transmitted diseases, and the implications of the "women's agenda."

Contraceptive Research and Development analyzes the response of the pharmaceutical industry to current dynamics in regulation, liability, public opinion, and the economics of the health sector and offers an integrated set of recommendations for public- and private-sector action to meet a whole new generation of demand.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!